Printer Friendly

MERIDIAN DIAGNOSTICS, INC. ANNOUNCES MANAGEMENT PROMOTIONS

 MERIDIAN DIAGNOSTICS, INC. ANNOUNCES MANAGEMENT PROMOTIONS
 CINCINNATI, Aug. 10 /PRNewswire/ -- Meridian Diagnostics, Inc. (NASDAQ/NMS: KITS), today announced the following appointments:
 Jerry L. Ruyan has been appointed chief executive officer of the company. Ruyan has served as the company's president since June 1986 and had previously served as chief operating officer from June 1986 through Jan. 1992. Prior to June 1986, he served as the company's vice president. Ruyan is a founder of the company and owns 1,713,109 shares (23 percent) of the company's outstanding common stock.
 John A. Kraeutler has been appointed president and chief operating officer of the company. Kraeutler joined the company in January of this year as executive vice president and chief operating officer. Kraeutler has extensive experience in the medical diagnostics industry with Carter-Wallace, Inc. where he served as vice president and general manager of the Medical Systems Division. His previous experience with Carter-Wallace was as vice president of marketing of the Wampole Laboratories Division. Kraeutler also worked for Becton Dickinson, Inc. as director of marketing and Organon, Inc. in product management. Kraeutler holds an M.B.A. in marketing and an M.S. in biology from Seton Hall University.
 William J. Motto, chairman, stated that the changes in management positions are consistent with the company's plans to continue to build its management team in line with the recent and expected growth of the business. He went on to say that Kraeutler had earned the respect and confidence of he and Ruyan since he joined the company earlier this year. Motto is a founder of the company and owns 2,989,255 shares (41 percent) of the company's common stock.
 Meridian Diagnostics, Inc. develops, manufactures and markets a variety of immunodiagnostic test kits, purified reagents such as antigens and monoclonal and polyclonal antibodies, and related diagnostic products. The company is a leader in the area of rapid diagnosis of infectious human diseases. All Meridian products are used outside the human body and require little or no special instrumentation or equipment. Domestic and international market segments consist of hospital, commercial and reference laboratories, and physicians' offices. The company has a leading market position in fungal serology, and is the leader in parasite and bacterial collection, preservation and transportation systems. The company's shares are traded through NASDAQ/NMS (Symbol: KITS).
 -0- 8/10/92
 /CONTACT: William J. Motto, chairman of Meridian Diagnostics, Inc., 513-271-3700/
 (KITS) CO: Meridian Diagnostics, Inc. ST: Ohio IN: MTC SU: PER


BM -- CL012 -- 8554 08/10/92 13:36 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 10, 1992
Words:419
Previous Article:FAA PROPOSES TO ESTABLISH FLIGHT SIMULATOR TRAINING CENTERS FOR PILOTS
Next Article:SHASTA HOLDINGS, INC., RELOCATES TO BEAVER COUNTY; CITES ELECTRIC RATES AND TRANSMISSION PROJECT AS FACTORS
Topics:


Related Articles
MERIDIAN EXPANDS MANAGEMENT TEAM AND APPOINTS EXECUTIVE VICE PRESIDENT
MERIDIAN RELEASES FOURTH PREMIER(TM) ENZYME IMMUNOASSAY
MERIDIAN LICENSES FILTRACHECK-UTI TO BIOSTAR, INC. FOR SALES TO THE ALTERNATE SITE MARKETPLACE
MERIDIAN TO MARKET PREMIER GIARDIA A DIAGNOSTIC TEST FOR GIARDIA LAMBLIA, THE MOST COMMON PARASITIC DISEASE IN THE UNITED STATES
MERIDIAN DIAGNOSTICS ANNOUNCES RECORD THIRD QUARTER AND NINE MONTH SALES AND EARNINGS AND DECLARES REGULAR QUARTERLY DIVIDEND
MERIDIAN DIAGNOSTICS ANNOUNCES RECORD SALES AND PROFITS, FOR FISCAL 1995 AND EXPECTS RECORD FISCAL 1996 OPERATING RESULTS
MERIDIAN ANNOUNCES RECORD SALES AND EARNINGS FOR THE FIRST QUARTER OF FISCAL 1996
Meridian Receives FDA Clearance To Market Whole Blood Test For Stomach Ulcers
Meridian Announces Second Quarter And First Half Operating Results And Announces Regular Quarterly Dividend
Meridian Diagnostics Signs Distribution Agreement with Toray-Fuji Bionics, Inc. of Japan

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters